The Proposed Vitamin D–Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes
Nutrients · 2026
DOI: 10.3390/nu18193167 ↗At a glance
Übersichtsarbeit in Nutrients, 2026. Written by Yun-Ah Lee and 1 co-authors. Institution: Department of Family Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 16247, Republic of Korea. Major MEDLINE topics: Homocysteine, Vitamin D, Cardiovascular Diseases. 69 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
The clinical relevance of a proposed relationship between vitamin D status and homocysteine remains uncertain. This narrative review integrates mechanistic, observational, Mendelian randomization (MR), and trial evidence. A documented supplementary search of PubMed and Europe PMC was executed on 21 September 2026 for publications through 31 July 2026; no formal risk-of-bias assessment or quantitative synthesis was performed. Experimental studies support vitamin D-dependent regulation of homocysteine metabolism and homocysteine-related suppression of vitamin D signaling, but reciprocal regulation has not been established in humans. Human biomarker associations and supplementation effects on homocysteine are heterogeneous; two frequently cited intervention publications report the same trial. Additional longitudinal and multibiomarker studies provide preliminary outcome associations, without externally validating the proposed four-category classification or its treatment utility. Homocysteine MR signals are more consistent for stroke than coronary disease, subject to validity and multiplicity concerns. Vitamin D MR is predominantly null, including the republished stratified analysis, and large supplementation trials have not demonstrated consistent cardiovascular benefit. A combined folate–vitamin D cognitive trial did not demonstrate its primary intention-to-treat benefit and does not validate vascular treatment selection. Clinical outcome trials carry greater weight for treatment decisions than molecular plausibility or biomarker co-occurrence. The proposed classification and explanatory models remain hypothesis-generating: a clinically meaningful reciprocal axis and differential benefit from phenotype-guided combined nutritional intervention are unproven.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Family Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 16247, Republic of Korea.
ORCID profiles: Sung-Goo Kang
Cite
APA
Lee, Y. A., & Kang, S. G. (2026). The Proposed Vitamin D–Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes. Nutrients. https://doi.org/10.3390/nu18193167
Vancouver
Lee YA, Kang SG. The Proposed Vitamin D–Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes. Nutrients. 2026. doi:10.3390/nu18193167
BibTeX
@article{Lee2026,
author = {Lee, Yun-Ah and Kang, Sung-Goo},
title = {The Proposed Vitamin D–Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18193167}
}
EUVIMED